Ticker Symbol | Entity Name | As Of Date | Company Name | Followers | Employees on Linkedin | Link | Industry | Date Added | Date Updated | Description | Website | Specialities | Logo | HQ.Street | HQ.City | HQ.State | HQ.Country | HQ.Postal | Headcount change in past 24 months | Company Name | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
private:excisionbio | 20282068 | Apr 21st, 2024 12:00AM | Excision BioTherapeutics | 4.2K | 46.00 | Open | Apr 21st, 2024 06:01AM | Apr 21st, 2024 06:01AM | Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world. | Open | Open | San Francisco | CA | US | Excision BioTherapeutics | |||||||
private:excisionbio | 20282068 | Apr 20th, 2024 12:00AM | Excision BioTherapeutics | 4.2K | 46.00 | Open | Apr 20th, 2024 05:00AM | Apr 20th, 2024 08:18PM | Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world. | Open | Open | San Francisco | CA | US | Excision BioTherapeutics | |||||||
private:excisionbio | 20282068 | Apr 19th, 2024 12:00AM | Excision BioTherapeutics | 4.2K | 46.00 | Open | Apr 19th, 2024 07:24AM | Apr 19th, 2024 07:24AM | Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world. | Open | Open | San Francisco | CA | US | Excision BioTherapeutics | |||||||
private:excisionbio | 20282068 | Apr 18th, 2024 12:00AM | Excision BioTherapeutics | 4.2K | 46.00 | Open | Apr 18th, 2024 06:05AM | Apr 18th, 2024 09:37PM | Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world. | Open | Open | San Francisco | CA | US | Excision BioTherapeutics | |||||||
private:excisionbio | 20282068 | Apr 17th, 2024 12:00AM | Excision BioTherapeutics | 4.2K | 47.00 | Open | Apr 17th, 2024 07:24AM | Apr 17th, 2024 06:05PM | Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world. | Open | Open | San Francisco | CA | US | Excision BioTherapeutics | |||||||
private:excisionbio | 20282068 | Apr 16th, 2024 12:00AM | Excision BioTherapeutics | 4.2K | 47.00 | Open | Apr 16th, 2024 04:50AM | Apr 16th, 2024 02:23PM | Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world. | Open | Open | San Francisco | CA | US | Excision BioTherapeutics | |||||||
private:excisionbio | 20282068 | Apr 15th, 2024 12:00AM | Excision BioTherapeutics | 4.2K | 47.00 | Open | Apr 15th, 2024 07:44AM | Apr 15th, 2024 08:04PM | Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world. | Open | Open | San Francisco | CA | US | Excision BioTherapeutics | |||||||
private:excisionbio | 20282068 | Apr 14th, 2024 12:00AM | Excision BioTherapeutics | 4.2K | 47.00 | Open | Apr 14th, 2024 03:41AM | Apr 14th, 2024 03:41AM | Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world. | Open | Open | San Francisco | CA | US | Excision BioTherapeutics | |||||||
private:excisionbio | 20282068 | Apr 13th, 2024 12:00AM | Excision BioTherapeutics | 4.2K | 47.00 | Open | Apr 13th, 2024 02:38AM | Apr 13th, 2024 02:46PM | Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world. | Open | Open | San Francisco | CA | US | Excision BioTherapeutics | |||||||
private:excisionbio | 20282068 | Apr 12th, 2024 12:00AM | Excision BioTherapeutics | 4.2K | 47.00 | Open | Apr 12th, 2024 02:49AM | Apr 12th, 2024 11:51AM | Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world. | Open | Open | San Francisco | CA | US | Excision BioTherapeutics |